ישראל - עברית - Ministry of Health

vitamed ltd,binyamina - cefazolin sodium 1000 mg/vial - powder for solution for injection - cefazolin - kefazin is indicated for the treatment of infections due to susceptible organisms.

ישראל - עברית - Ministry of Health

masrouji company ltd - cefazolin as sodium 500 mg/vial - powder for solution for injection - cefazolin - treatment of serious infections caused by susceptible organisms and also perioperatively for prophylaxis. treatment respiratory tract: respiratory tract infections due to streptococcus pneumoniae (formerly diplococcus pneumoniae) klebsiella species haemophilus influenzae staphylococcus aureus (penicillin-sensitive and penicillin-resistant) and group a b - hemolytic streptococci. cefazolin is effective in the eradication of streptococci from the nasopharynx. however data establishing the efficacy of cefazolin in the subsequent prevention of rheumatic fever are not available at present. urinary tract: infections due to escherichia coli klebsiella species proteus mirabilis and some strains of enterobacter and enterococci. skin and skin structure: -hemolytic beta infections due to staphylococcus aureus (penicillin-sensitive and penicillin-resistant) group a streptococci and other strains of streptococci. biliary tract: infections due to escherichia coli various strains of streptococci proteus mirabilis klebsiella

ישראל - עברית - Ministry of Health

vitamed ltd,binyamina - cefuroxime as sodium 750 mg/vial - powder for solution for injection - cefuroxime - for the treatment of diseases caused by micro-organisms sensitive to cefuroxime.

ישראל - עברית - Ministry of Health

vitamed ltd,binyamina - cefotaxime as sodium 1000 mg/vial - powder for solution for injection - cefotaxime - for the treatment of disease caused by micro-organisms sensitive to cefotaxime.

ישראל - עברית - Ministry of Health

abic marketing ltd - ceftazidime as pentahydrate 2 g/vial - powder for solution for injection - ceftazidime - treatment of single or multiple infections caused by susceptible microorganisms.

ישראל - עברית - Ministry of Health

roche pharmaceuticals (israel) ltd - ceftriaxone as sodium 1000 mg/vial - powder and solvent for solution for injection - ceftriaxone - long-acting, broad spectrum cephalosporin, for the treatment of infections caused by susceptible organisms.

ישראל - עברית - Ministry of Health

merck sharp & dohme israel ltd - cilastatin sodium 500 mg/vial; imipenem as monohydrate 500 mg/vial - powder for solution for injection - imipenem and enzyme inhibitor - infections caused by susceptible microorganisms.

ישראל - עברית - Ministry of Health

medison pharma ltd - daptomycin 500 mg/vial - lyophilized powder for injection - daptomycin - cubicin (daptomycin for injection) is indicated for the treatment of complicated skin and skin structure infections caused by susceptible strains of the following gram-positive microorganisms: staphylococcus aureus (including methicillin-resistant strains) streptococcus pyogenes streptococcus agalactiae streptococcus dysgalactiae subsp. equisimilis and enterococcus faecalis (vancomycin-susceptible strains only). combination therapy may be clinically indicated if the documented or presumed pathogens include gram-negative or anaerobic organisms. daptomycin is not indicated for the treatment of pneumonia. appropriate specimens for microbiological examination should be obtained in order to isolate and identify the causative pathogens and to determine their susceptibility to daptomycin. empiric therapy may be initiated while awaiting test results. antimicrobial therapy should be adjusted as needed based upon test results. to reduce the development of drug-resistant bacteria and maintain the effectiveness of cubici

ישראל - עברית - Ministry of Health

pfizer pharmaceuticals israel ltd - voriconazole 200 mg/vial - powder for solution for infusion - voriconazole - treatment of : - invasive aspergillosis fluconazole-resistant serious invasive candida infections (including c. krusei), - serious fungal infections caused by scedosporium spp. and fusarium spp.vfend should be administered primarily to immunocompromised patients with progressive possibly life-threatening infections. treatment of candidemia in non neutropenic patients.

ישראל - עברית - Ministry of Health

glaxo smith kline (israel) ltd - aciclovir - אבקה להכנת תמיסה לאינפוזיה - aciclovir 250 mg/vial - aciclovir - aciclovir - for the treatment of herpes simplex infections and severe initial genital herpes in the non immunocompromised. for the prophylaxis of herpes simplex infections in immune-compromised patients. in the treatment of varicella zoster infections. for herpes simplex encephalitis. for the treatment of herpes simplex infection in the neonate and infant up to 3 months of age.